SCPHARMACEUTICALS INC (SCPH) Earnings History & Surprises
NASDAQ:SCPH • US8106481059
5.67 USD
0 (0%)
At close: Oct 6, 2025
5.77 USD
+0.1 (+1.76%)
After Hours: 10/6/2025, 9:01:22 PM
Past quarterly earnings results for SCPHARMACEUTICALS INC (SCPH), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateNov 5, 2025
PeriodQ3 / 2025
EPS Estimate-$0.24
Revenue Estimate20.051M
Last Reported
Release DateAug 7, 2025
PeriodQ2 / 2025
EPS Reported-$0.34
EPS Surprise -11.86%
Revenue Surprise 2.03%
Beat Rate
44%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q2 2025 | -0.34 | -0.30 | -11.86% | 22.73% | 16.041M | 15.722M | 2.03% | 99.17% |
| Q1 2025 | -0.37 | -0.30 | -21.73% | -2.78% | 11.752M | 11.861M | -0.92% | 92.59% |
| Q4 2024 | -0.35 | -0.39 | 9.30% | - | 12.15M | 12.326M | -1.43% | 99.31% |
| Q3 2024 | -0.75 | -0.30 | -147.99% | -82.93% | 10.026M | 11.017M | -9.00% | 164.12% |
| Q2 2024 | -0.44 | -0.42 | -4.20% | -22.22% | 8.054M | 8.129M | -0.92% | 391.70% |
| Q1 2024 | -0.36 | -0.45 | 19.24% | -20.00% | 6.102M | 6.097M | 0.08% | 195.78% |
| Q4 2023 | -0.35 | -0.43 | 18.07% | -16.67% | 6.096M | 5.636M | 8.16% | - |
| Q3 2023 | -0.41 | -0.37 | -10.18% | -10.81% | 3.796M | 3.459M | 9.74% | - |
| Q2 2023 | -0.36 | -0.38 | 5.23% | -2.86% | 1.638M | 1.65M | -0.73% | - |
| Q1 2023 | -0.30 | -0.37 | 19.42% | -7.14% | 2.063M | 1.394M | 47.99% | - |
| Q4 2022 | -0.30 | -0.39 | 24.00% | -11.11% | - | - | ||
| Q3 2022 | -0.37 | -0.39 | 5.16% | -54.17% | - | - | ||
| Q2 2022 | -0.35 | -0.31 | -13.12% | -34.62% | - | - | ||
| Q1 2022 | -0.28 | -0.32 | 11.45% | -7.69% | - | - | ||
| Q4 2021 | -0.27 | -0.35 | 22.90% | 3.57% | - | - | ||
| Q3 2021 | -0.24 | -0.32 | 24.91% | 27.27% | - | - | ||
| Q2 2021 | -0.26 | -0.31 | 15.03% | 27.78% | - | - | ||
| Q1 2021 | -0.26 | -0.31 | 15.03% | 25.71% | - | - | ||
| Q4 2020 | -0.28 | -0.37 | 24.45% | - | - | - | ||
| Q3 2020 | -0.33 | -0.39 | 15.42% | - | - | - | ||
| Q2 2020 | -0.36 | -0.43 | 16.46% | - | - | - | ||
| Q1 2020 | -0.35 | -0.55 | 36.16% | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
1
Average EPS beat (4)
-43.07%
Max EPS beat (4)
9.30%
Min EPS beat (4)
-147.99%
Revenue beat statistics
Revenue beat (4)
1
Average Revenue beat (4)
-2.33%
Max Revenue beat (4)
2.03%
Min Revenue beat (4)
-9.00%
Analysis
In the last 4 quarters, SCPH has beaten EPS estimates in 1 out of 4 releases
SCPH has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, SCPH reported -43.1% below the EPS estimates on average.
In the last 4 quarters, SCPH reported -2.3% below the revenue estimates on average.
SCPHARMACEUTICALS INC / SCPH Earnings FAQ
When did SCPHARMACEUTICALS INC (SCPH) report earnings last quarter?
SCPHARMACEUTICALS INC (SCPH) last reported earnings on 8/7/2025.
Did SCPHARMACEUTICALS INC (SCPH) beat earnings estimates last quarter?
SCPHARMACEUTICALS INC (SCPH) missed EPS estimates and beat revenue estimates in the most recent quarter.
Can you provide information on how often SCPHARMACEUTICALS INC beats earnings estimates?
In the last 4 quarters, SCPHARMACEUTICALS INC (SCPH) has beaten EPS estimates in 1 out of 4 releases.